BioPorto AS (0JJM) Stock Statistics & Valuation Metrics
Total Valuation
BioPorto AS has a market cap or net worth of DKK 505.00M. The enterprise value is DKK 464.96M.
- Market Cap
- DKK 505.00M
- Enterprise Value
- DKK 464.96M
Share Statistics
BioPorto AS has 495,108,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 495,108,900
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
BioPorto AS’s return on equity (ROE) is -1.01 and return on invested capital (ROIC) is -88.42%.
- Return on Equity (ROE)
- -1.01
- Return on Assets (ROA)
- -0.71
- Return on Invested Capital (ROIC)
- -88.42%
- Return on Capital Employed (ROCE)
- -1.00
- Revenue Per Employee
- 823.70K
- Profits Per Employee
- -1.55M
- Employee Count
- 44
- Asset Turnover
- 0.38
- Inventory Turnover
- 2.52
Valuation Ratios
The current PE Ratio of BioPorto AS is -7.37. BioPorto AS’s PEG ratio is 0.42.
- PE Ratio
- -7.37
- PS Ratio
- 18.61
- PB Ratio
- 14.62
- Price to FCF
- -7.23
- Price to Operating Cash Flow
- -6.96
- PEG Ratio
- 0.42
Income Statement
In the last 12 months, BioPorto AS had revenue of 36.24M and earned -68.24M in profits. Earnings per share was -0.17.
- Revenue
- 36.24M
- Gross Profit
- 24.53M
- Operating Income
- -75.45M
- Pretax Income
- -73.74M
- Net Income
- -68.24M
- EBITDA
- -70.53M
- Earnings Per Share (EPS)
- -0.17
Cash Flow
In the last 12 months, operating cash flow was -86.99M and capital expenditures -1.72M, giving a free cash flow of -88.71M billion.
- Operating Cash Flow
- -86.99M
- Free Cash Flow
- -88.71M
- Free Cash Flow per Share
- -0.21
Dividends & Yields
BioPorto AS pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -13.84%
- Earnings Yield
- -13.56%
Stock Price Statistics
- Beta
- -0.01
- 52-Week Price Change
- -1.31%
- 50-Day Moving Average
- 1.11
- 200-Day Moving Average
- 1.19
- Relative Strength Index (RSI)
- 12.11
- Average Volume (3m)
- 1,018
Important Dates
BioPorto AS upcoming earnings date is Nov 19, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 20, 2026
- Next Earnings Date
- Nov 19, 2026
- Ex-Dividend Date
- ―
Financial Position
BioPorto AS as a current ratio of 4.12, with Debt / Equity ratio of 16.51%
- Current Ratio
- 4.12
- Quick Ratio
- 3.89
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.69
- Interest Coverage Ratio
- -90.47
Taxes
In the past 12 months, BioPorto AS has paid -5.50M in taxes.
- Income Tax
- -5.50M
- Effective Tax Rate
- 0.07
Enterprise Valuation
BioPorto AS EV to EBITDA ratio is -7.11, with an EV/FCF ratio of -6.97.
- EV to Sales
- 17.95
- EV to EBITDA
- -7.11
- EV to Free Cash Flow
- -6.97
- EV to Operating Cash Flow
- -7.11
Balance Sheet
BioPorto AS has DKK 32.84M in cash and marketable securities with DKK 10.24M in debt, giving a net cash position of DKK 22.61M billion.
- Cash & Marketable Securities
- DKK 32.84M
- Total Debt
- DKK 10.24M
- Net Cash
- DKK 22.61M
- Net Cash Per Share
- DKK 0.05
- Tangible Book Value Per Share
- DKK 0.10
Margins
Gross margin is 64.64%, with operating margin of -265.73%, and net profit margin of -238.46%.
- Gross Margin
- 64.64%
- Operating Margin
- -265.73%
- Pretax Margin
- -261.58%
- Net Profit Margin
- -238.46%
- EBITDA Margin
- -252.63%
- EBIT Margin
- -259.68%
Analyst Forecast
The average price target for BioPorto AS is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 11.16%
- EPS Growth Forecast
- -8.90%